Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 12/20 | 0.47 |
| ▸ | ACACB | O00763 | 1/20 | 0.42 |
| ▸ | ACACA | Q13085 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14945519 | 0.86 | ACACB (0.43) | ADORA2BACACBACACAKMT2A | |
| SCHEMBL14945781 | 0.85 | ADORA2B (0.42) | ADORA2BACACBACACAKMT2AMEN1 | |
| SCHEMBL14945809 | 0.85 | ADORA2B (0.42) | ADORA2BACACBACACAKMT2AMEN1 | |
| SCHEMBL14936354 | 0.84 | ACACB (0.56) | ADORA2BACACBACACAKMT2AMEN1 | |
| SCHEMBL14935875 | 0.84 | ACACB (0.56) | ADORA2BACACBACACAKMT2AMEN1 | |
| SCHEMBL14935877 | 0.84 | ACACB (0.56) | ADORA2BACACBACACAKMT2AMEN1 | |
| SCHEMBL14945774 | 0.84 | ACACB (0.47) | ADORA2BACACBACACAKMT2AMEN1 | |
| SCHEMBL20053017 | 0.82 | MAPT (0.45) | ADORA2BACACBACACAKMT2AMEN1 | |
| SCHEMBL21548287 | 0.82 | ADORA2B (0.44) | ADORA2BACACBACACAKMT2AMEN1 | |
| SCHEMBL14945518 | 0.79 | ACACB (0.45) | ADORA2BACACBACACAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3329919-A1 | ACC INHIBITORS AND USES THEREOF | Gilead Apollo, LLC (US) | 2018-06-06 | — | — | EP | disclosed |